211 related articles for article (PubMed ID: 24820317)
1. Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices.
Liu J; Li S; Gilbertson DT; Monda KL; Bradbury BD; Collins AJ
Am J Kidney Dis; 2014 Oct; 64(4):608-15. PubMed ID: 24820317
[TBL] [Abstract][Full Text] [Related]
2. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.
Collins AJ; Monda KL; Molony JT; Li S; Gilbertson DT; Bradbury BD
Am J Kidney Dis; 2014 Jun; 63(6):997-1006. PubMed ID: 24315770
[TBL] [Abstract][Full Text] [Related]
3. Blood transfusion practices in dialysis patients in a dynamic regulatory environment.
Hirth RA; Turenne MN; Wilk AS; Wheeler JR; Sleeman KK; Zhang W; Paul MA; Nahra TA; Messana JM
Am J Kidney Dis; 2014 Oct; 64(4):616-21. PubMed ID: 24560166
[TBL] [Abstract][Full Text] [Related]
4. Effects of the prospective payment system on anemia management in maintenance dialysis patients: implications for cost and site of care.
Wetmore JB; Tzivelekis S; Collins AJ; Solid CA
BMC Nephrol; 2016 May; 17(1):53. PubMed ID: 27228981
[TBL] [Abstract][Full Text] [Related]
5. RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL.
Gilbertson DT; Monda KL; Bradbury BD; Collins AJ
Am J Kidney Dis; 2013 Nov; 62(5):919-28. PubMed ID: 23815986
[TBL] [Abstract][Full Text] [Related]
6. Hemodialysis patients' preferences for the management of anemia.
Hauber B; Caloyeras J; Posner J; Brommage D; Tzivelekis S; Pollock A
BMC Nephrol; 2017 Jul; 18(1):253. PubMed ID: 28750609
[TBL] [Abstract][Full Text] [Related]
7. Arteriovenous Fistula Use in the United States and Dialysis Facility-Level Comorbidity Burden.
Dahlerus C; Kim S; Chen S; Segal JH
Am J Kidney Dis; 2020 Jun; 75(6):879-886. PubMed ID: 31767192
[TBL] [Abstract][Full Text] [Related]
8. Does One Size Fit All With the Effects of Payment Reform? Dialysis Facility Payer Mix and Anemia Management Under the Expanded Medicare Prospective Payment System.
Mukhopadhyay P; Pearson J; Cogan C; Gaber C; Gillespie BW; Turenne M
Med Care; 2019 Aug; 57(8):584-591. PubMed ID: 31295188
[TBL] [Abstract][Full Text] [Related]
9. Effects of Epoetin Alfa Titration Practices, Implemented After Changes to Product Labeling, on Hemoglobin Levels, Transfusion Use, and Hospitalization Rates.
Molony JT; Monda KL; Li S; Beaubrun AC; Gilbertson DT; Bradbury BD; Collins AJ
Am J Kidney Dis; 2016 Aug; 68(2):266-276. PubMed ID: 26980607
[TBL] [Abstract][Full Text] [Related]
10. Red blood cell transfusion use in patients with chronic kidney disease.
Gill KS; Muntner P; Lafayette RA; Petersen J; Fink JC; Gilbertson DT; Bradbury BD
Nephrol Dial Transplant; 2013 Jun; 28(6):1504-15. PubMed ID: 23389999
[TBL] [Abstract][Full Text] [Related]
11. Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.
Brown J; Josephson M
Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S85-94. PubMed ID: 11053593
[TBL] [Abstract][Full Text] [Related]
12. Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS).
Brunelli SM; Monda KL; Burkart JM; Gitlin M; Neumann PJ; Park GS; Symonian-Silver M; Yue S; Bradbury BD; Rubin RJ
Am J Kidney Dis; 2013 Jun; 61(6):947-56. PubMed ID: 23332991
[TBL] [Abstract][Full Text] [Related]
13. Temporal trends in red blood transfusion among US dialysis patients, 1992-2005.
Ibrahim HN; Ishani A; Foley RN; Guo H; Liu J; Collins AJ
Am J Kidney Dis; 2008 Dec; 52(6):1115-21. PubMed ID: 18823686
[TBL] [Abstract][Full Text] [Related]
14. Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis.
Naci H; de Lissovoy G; Hollenbeak C; Custer B; Hofmann A; McClellan W; Gitlin M
J Med Econ; 2012; 15(2):293-304. PubMed ID: 22115328
[TBL] [Abstract][Full Text] [Related]
15. Impact of facility size and profit status on intermediate outcomes in chronic dialysis patients.
Frankenfield DL; Sugarman JR; Presley RJ; Helgerson SD; Rocco MV
Am J Kidney Dis; 2000 Aug; 36(2):318-26. PubMed ID: 10922310
[TBL] [Abstract][Full Text] [Related]
16. Standardized Transplantation Referral Ratio to Assess Performance of Transplant Referral among Dialysis Facilities.
Paul S; Plantinga LC; Pastan SO; Gander JC; Mohan S; Patzer RE
Clin J Am Soc Nephrol; 2018 Feb; 13(2):282-289. PubMed ID: 29371341
[TBL] [Abstract][Full Text] [Related]
17. Anemia in patients on chronic hemodialysis in Cameroon: prevalence, characteristics and management in low resources setting.
Kaze FF; Kengne AP; Mambap AT; Halle MP; Mbanya D; Ashuntantang G
Afr Health Sci; 2015 Mar; 15(1):253-60. PubMed ID: 25834556
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
19. Dialysis facility characteristics and variation in employment rates: a national study.
Kutner N; Bowles T; Zhang R; Huang Y; Pastan S
Clin J Am Soc Nephrol; 2008 Jan; 3(1):111-6. PubMed ID: 18178781
[TBL] [Abstract][Full Text] [Related]
20. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.
Garg PP; Frick KD; Diener-West M; Powe NR
N Engl J Med; 1999 Nov; 341(22):1653-60. PubMed ID: 10572154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
